109
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical Evaluation of Carbamazepine Microparticles Produced by the Rapid Expansion of Supercritical Solutions and by Spray-Drying

RESEARCH ARTICLE

, , , , &
Pages 11-20 | Received 31 Jan 2002, Accepted 14 Jul 2002, Published online: 20 Feb 2003

REFERENCES

  • Moneghini M., Kikic I., Voinovich D., Perissutti B., Filipovic-Grcic J. Processing of carbamazepine PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution. Int. J. Pharm. 2001; 222: 129–138
  • Howarth P.H. Why particle size should affect clinical response to inhaled therapy. J. Aerosol Med. 2001; 14: S27–S34
  • Medina J., Salvado A., del Pozo A. Use of ultrasound to prepare lipid emulsions of lorazepam for intravenous injection. Int. J. Pharm. 2001; 216: 1–8
  • Sun C., Grant D.J. Effects of initial particle size on the tableting properties of L-lysine monohydrochloride dihydrate powder. Int. J. Pharm. 2001; 215: 221–228
  • Brodhead J., Rhodes C.T. The spray drying of pharmaceuticals. Drug Dev. Ind. Pharm. 1992; 12: 1169–1206
  • Brodhead J., Rouan S.K., Rhodes C.T. The effect of process and formulation variables on the properties of spray-dried-galactosidase. J. Pharm. Pharmacol. 1994; 46: 458–467
  • Billon A., Bataille B., Cassanas G., Jacob M. Development of spray-dried acetaminophen microparticles using experimental designs. Int. J. Pharm. 2000; 203: 159–168
  • Helfgen B., Turk M., Schaber K. Theoretical and experimental investigations of the micronization of organic solids by rapid expansion of supercritical solutions. Powder Tech. 2000; 110: 22–28
  • Turk M. Formation of small organic particles by RESS: experimental and theoretical investigations. J. Super. Fluids 1999; 15: 79–89
  • Charoenchaitrakool M., Dehghani F., Foster N.R., Chan H.K. Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind. & Eng. Chem. Res. 2000; 39: 4794–4802
  • Krahn F.U., Mielck J.B. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm. Acta Helv. 1987; 62: 247–254
  • Rustichelli C., Gamberini G., Ferioli V., Gamberini M.C., Ficarra R., Tommasini S. Solid-state study of polymorphic drugs: carbamazepine. J. Pharm. & Bio. Anal. 2000; 23: 41–54
  • Matsuda Y., Akasawa R., Teraoka R., Otsuka M. Pharmaceutical evaluation of carbamazepine modifications: Comparative study for photostability of carbamazepine polymorphs by using Fourier-transformed reflection-absorption infrared spectroscopy and colorimetric measurement. J. Pharm. Pharmacol. 1994; 46: 162–167
  • Ceolin R., Toscani S., Gardette M.F., Agafonov V.N., Dzyabchenko A.V., Bachet B. X-ray characterization of the triclinic polymorph of carbamazepine. J. Pharm. Sc. 1997; 86: 1062–1065
  • , The United States Pharmacopeia, XXIV revision. United States Pharmacopeial Convention, Rockville, MD, 1999.
  • , International Centre for Diffraction Data (ICDD). Beta-carbamazepine. USA reference 33-1565. 1995, 28, pp. 24.
  • Lowes M.M.J., Caira M.R., Lotter A.P., Van Der Watt J.G. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J. Pharm. Sci. 1987; 76: 744–752
  • , International Centre for Diffraction Data (ICDD). Alpha-carbamazepine. USA reference 33-1566. 1995, 28, pp. 28.
  • Dugue J., Ceolin R., Rouland J.C., Lepage F. Polymorphism of carbamazepine: solid-state studies on carbamazepine dihydrate. Pharm. Acta Helv. 1991; 66: 307–310
  • McMahon L.E., Timmins P., Williams A.C., York P. Characterization of dihydrates prepared from carbamazepine polymorphs. J. Pharm. Sci. 1996; 85: 1064–1069
  • Klug H.P., Alexander L.E. X-ray diffraction procedures for polycrystalline and amorphous materials. 2nd Ed., Wiley, New York 1974; 716
  • Suryanarayanan R. H.G. BrittainX-ray powder diffractometry, . 1st Ed., Marcel Dekker Inc., New-York 1995; Vol. 70: 187–221
  • Suryanarayanan R. Determination of the relative amounts of anhydrous carbamazepine (C15H12N2O) and carbamazepine dihydrate (C15H12N2O·2H2O) in a mixture by powder X-ray diffractometry. Pharm. Res. 1989; 6: 1017–1024
  • Iyengar S.S., Phadnis N.V., Suryanarayanan R. Quantitative analyses of complex pharmaceutical mixtures by the Rietveld method. Powder Diffraction 2001; 16: 20–24
  • Fagel N., Robert C., Preda M., Thorez J. Smectite composition as a tracer of deep circulation: the case of the Northern North Atlantic. Marine Geology 2001; 172: 309–330
  • Jenkins R. Use of X-ray powder diffraction in the pharmaceutical industry. Am. Pharm. Rev. 2000; 3: 36–40
  • Suryanarayanan R., Mitchell A.G. Evaluation of two concepts of crystallinity using calcium gluceptate as a model compound. Int. J. Pharm. 1985; 24: 1–17
  • Behme R.J., Brooke D. Heat of fusion measurement of a low melting polymorph of carbamazepine that undergoes multiple-phase changes during differential scanning calorimetry analysis. J. Pharm. Sci. 1991; 80: 986–990
  • Masters K. Spray drying handbook. 4th Ed., Wiley, New York 1985; 696
  • Lacasse F.X., Hildgen P., McMullen J.N. Surface and morphology of spray-dried pegylated PLA microspheres. Int. J. Pharm. 1998; 174: 101–109

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.